Eric Still
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
-
- Protein Degradation and Inhibitors 3
- Chromatin Remodeling and Cancer 2
- Cancer-related gene regulation 2
- Advanced biosensing and bioanalysis techniques 2
- CRISPR and Genetic Engineering 1
- Sphingolipid Metabolism and Signaling 1
- Co-authors
- Alex Kentsis (3 shared papers)Fiona C. Brown (2 shared papers)Scott A. Armstrong (1 shared paper)Michael G. Kharas (1 shared paper)Tatyana S. Gindin (1 shared paper)Elisa de Stanchina (1 shared paper)Kavitha Ramaswamy (1 shared paper)Gerard Minuesa (1 shared paper)
- Journals
- Blood (1 paper)British Journal of Haematology (1 paper)Nature Communications (1 paper)Nature Genetics (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Eric Still
10 papers receiving 330 citations
Peers
Comparison fields: 5 of 53
- Hematology 80
- Cancer Research 53
- Molecular Biology 254
- Oncology 52
- Genetics 41
Countries citing papers authored by Eric Still
This map shows the geographic impact of Eric Still's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Still with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Still more than expected).
Fields of papers citing papers by Eric Still
This network shows the impact of papers produced by Eric Still. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Still. The network helps show where Eric Still may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Still, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 79 | |
| 2 | 2017 | 68 | |
| 3 | 2015 | 64 | |
| 4 | 2018 | 61 | |
| 5 | 2016 | 26 | |
| 6 | 2012 | 23 | |
| 7 | 2013 | 8 | |
| 8 | 2013 | 6 | |
| 9 | 2010 | 1 | |
| 10 | 2017 | 1 |
About Eric Still
Eric Still is a scholar working on Hematology, Molecular Biology, Toxicology, Oncology and Cancer Research, having authored 10 papers that have together received 337 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Acute Myeloid Leukemia Research (2 papers), Chromatin Remodeling and Cancer (2 papers), Cancer-related gene regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Multiple Myeloma Research and Treatments (2 papers), CRISPR and Genetic Engineering (1 paper) and Sphingolipid Metabolism and Signaling (1 paper). The work is most often cited by research in Hematology (80 citations), Cancer Research (53 citations), Molecular Biology (254 citations), Oncology (52 citations) and Genetics (41 citations). Eric Still has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Alex Kentsis, Fiona C. Brown, Scott A. Armstrong, Michael G. Kharas, Tatyana S. Gindin, Elisa de Stanchina, Kavitha Ramaswamy, Gerard Minuesa, Birgit Knoechel and Andrei V. Krivtsov. Their work appears in journals such as Blood, British Journal of Haematology, Nature Communications, Nature Genetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.